Publication
2nd Circuit defers to executive will on application of sovereign immunity
The Second Circuit recently held that federal common law protections of sovereign immunity did not preclude prosecution of a state-owned foreign corporation.
With this issue, I am pleased to have the opportunity to congratulate my partner and co-head of the Norton Rose Fulbright restructuring group, Scott Atkins, on an extremely successful three-year term as president of INSOL International. INSOL is the leading global organization of insolvency professionals.
Scott was instrumental in developing a comprehensive strategic review of INSOL through the landmark INSOL 2030 Strategic Plan and by leading several new future-shaping initiatives to enable INSOL to continue to serve its members in the decade to come.
Scott led the INSOL conferences in London 2022, in Tokyo 2023 and, most recently, in San Diego 2024. These were milestone events for INSOL, including celebrating INSOL’s 40th anniversary and driving membership growth to a record 12,300 members from over 108 countries.
As the co-leader of our Restructuring group, Scott provides a fantastic global perspective to help us advise our clients through these turbulent times. Scott’s clear and strategic leadership will be invaluable as the world realigns around geopolitical and technological disruption.
Good reading,
Howard Seife
Global Co-Head of Restructuring
New York
Publication
The Second Circuit recently held that federal common law protections of sovereign immunity did not preclude prosecution of a state-owned foreign corporation.
Publication
Facing the fast-growing development of AI across the globe, particularly Generative AI (GenAI), the G7 competition authorities and policymakers (Canada, France, Germany, Japan, Italy, the UK and the US) and the European Commission met in Italy on 3-4 October 2024 to discuss the main competition challenges raised by these new technologies in digital markets.
Subscribe and stay up to date with the latest legal news, information and events . . .
© Norton Rose Fulbright LLP 2023